NEW YORK ( TheStreet) -- Luminex Corporation (Nasdaq: LMNX) hit a new 52-week high Tuesday as it is currently trading at $22.51, above its previous 52-week high of $21.89 with 284,119 shares traded as of 10:06 a.m. ET. Average volume has been 174,400 shares over the past 30 days.

Luminex has a market cap of $828.3 million and is part of the health care sector and health services industry. Shares are up 1.2% year to date as of the close of trading on Monday.

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the life sciences and diagnostic industries in the United States. The company has a P/E ratio of 109.3, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
  • Practice your LMNX trading strategies and win cash in our stock game.

TheStreet Ratings rates Luminex as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Luminex Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.